TY - JOUR AU - Wei, S. C. AU - Duffy, C. R. AU - Allison, J. P. PY - 2018 DA - 2018// TI - Fundamental mechanisms of immune checkpoint blockade therapy JO - Cancer Discov VL - 8 UR - https://doi.org/10.1158/2159-8290.CD-18-0367 DO - 10.1158/2159-8290.CD-18-0367 ID - Wei2018 ER - TY - JOUR AU - Andrews, L. P. AU - Marciscano, A. E. AU - Drake, C. G. AU - Vignali, D. A. PY - 2017 DA - 2017// TI - Lag3 (cd223) as a cancer immunotherapy target JO - Immunol Rev VL - 276 UR - https://doi.org/10.1111/imr.12519 DO - 10.1111/imr.12519 ID - Andrews2017 ER - TY - JOUR AU - Wolf, Y. AU - Anderson, A. C. AU - Kuchroo, V. K. PY - 2020 DA - 2020// TI - Tim3 comes of age as an inhibitory receptor JO - Nat Rev Immunol VL - 20 UR - https://doi.org/10.1038/s41577-019-0224-6 DO - 10.1038/s41577-019-0224-6 ID - Wolf2020 ER - TY - JOUR AU - Darvin, P. AU - Toor, S. M. AU - Sasidharan Nair, V. AU - Elkord, E. PY - 2018 DA - 2018// TI - Immune checkpoint inhibitors: recent progress and potential biomarkers JO - Exp Mol Med VL - 50 UR - https://doi.org/10.1038/s12276-018-0191-1 DO - 10.1038/s12276-018-0191-1 ID - Darvin2018 ER - TY - JOUR AU - Mir, H. AU - Alhussein, M. AU - Alrashidi, S. AU - Alzayer, H. AU - Alshatti, A. AU - Valettas, N. PY - 2018 DA - 2018// TI - Cardiac complications associated with checkpoint inhibition: a systematic review of the literature in an important emerging area JO - Can J Cardiol VL - 34 UR - https://doi.org/10.1016/j.cjca.2018.03.012 DO - 10.1016/j.cjca.2018.03.012 ID - Mir2018 ER - TY - JOUR AU - Lyon, A. R. AU - Yousaf, N. AU - Battisti, N. M. L. AU - Moslehi, J. AU - Larkin, J. PY - 2018 DA - 2018// TI - Immune checkpoint inhibitors and cardiovascular toxicity JO - Lancet Oncol VL - 19 UR - https://doi.org/10.1016/S1470-2045(18)30457-1 DO - 10.1016/S1470-2045(18)30457-1 ID - Lyon2018 ER - TY - JOUR AU - Tajmir-Riahi, A. AU - Bergmann, T. AU - Schmid, M. AU - Agaimy, A. AU - Schuler, G. AU - Heinzerling, L. PY - 2018 DA - 2018// TI - Life-threatening autoimmune cardiomyopathy reproducibly induced in a patient by checkpoint inhibitor therapy JO - J Immunother VL - 41 UR - https://doi.org/10.1097/CJI.0000000000000190 DO - 10.1097/CJI.0000000000000190 ID - Tajmir-Riahi2018 ER - TY - JOUR AU - Chauhan, A. AU - Burkeen, G. AU - Houranieh, J. AU - Arnold, S. AU - Anthony, L. PY - 2017 DA - 2017// TI - Immune checkpoint-associated cardiotoxicity: case report with systematic review of literature JO - Ann Oncol VL - 28 UR - https://doi.org/10.1093/annonc/mdx213 DO - 10.1093/annonc/mdx213 ID - Chauhan2017 ER - TY - JOUR AU - Puzanov, I. AU - Diab, A. AU - Abdallah, K. AU - Bingham, C. O. AU - Brogdon, C. AU - Dadu, R. PY - 2017 DA - 2017// TI - Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the society for immunotherapy of cancer (sitc) toxicity management working group JO - J Immunother Cancer. VL - 5 UR - https://doi.org/10.1186/s40425-017-0300-z DO - 10.1186/s40425-017-0300-z ID - Puzanov2017 ER - TY - JOUR AU - Brahmer, J. R. AU - Lacchetti, C. AU - Schneider, B. J. AU - Atkins, M. B. AU - Brassil, K. J. AU - Caterino, J. M. PY - 2018 DA - 2018// TI - Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: American society of clinical oncology clinical practice guideline JO - J Clin Oncol VL - 36 UR - https://doi.org/10.1200/JCO.2017.77.6385 DO - 10.1200/JCO.2017.77.6385 ID - Brahmer2018 ER - TY - JOUR AU - Ganatra, S. AU - Neilan, T. G. PY - 2018 DA - 2018// TI - Immune checkpoint inhibitor-associated myocarditis JO - Oncologist. VL - 23 UR - https://doi.org/10.1634/theoncologist.2018-0130 DO - 10.1634/theoncologist.2018-0130 ID - Ganatra2018 ER - TY - JOUR AU - Mahmood, S. S. AU - Fradley, M. G. AU - Cohen, J. V. AU - Nohria, A. AU - Reynolds, K. L. AU - Heinzerling, L. M. PY - 2018 DA - 2018// TI - Myocarditis in patients treated with immune checkpoint inhibitors JO - J Am Coll Cardiol VL - 71 UR - https://doi.org/10.1016/j.jacc.2018.02.037 DO - 10.1016/j.jacc.2018.02.037 ID - Mahmood2018 ER - TY - JOUR AU - Tison, G. H. AU - Chamberlain, A. M. AU - Pletcher, M. J. AU - Dunlay, S. M. AU - Weston, S. A. AU - Killian, J. M. PY - 2018 DA - 2018// TI - Identifying heart failure using emr-based algorithms JO - Int J Med Inform VL - 120 UR - https://doi.org/10.1016/j.ijmedinf.2018.09.016 DO - 10.1016/j.ijmedinf.2018.09.016 ID - Tison2018 ER - TY - JOUR AU - Cozzolino, F. AU - Montedori, A. AU - Abraha, I. AU - Eusebi, P. AU - Grisci, C. AU - Heymann, A. J. PY - 2019 DA - 2019// TI - A diagnostic accuracy study validating cardiovascular icd-9-cm codes in healthcare administrative databases. The umbria data-value project JO - PLoS One VL - 14 UR - https://doi.org/10.1371/journal.pone.0218919 DO - 10.1371/journal.pone.0218919 ID - Cozzolino2019 ER - TY - JOUR AU - Salem, J. E. AU - Manouchehri, A. AU - Moey, M. AU - Lebrun-Vignes, B. AU - Bastarache, L. AU - Pariente, A. PY - 2018 DA - 2018// TI - Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study JO - Lancet Oncol. VL - 19 UR - https://doi.org/10.1016/S1470-2045(18)30608-9 DO - 10.1016/S1470-2045(18)30608-9 ID - Salem2018 ER - TY - JOUR AU - Johnson, D. B. AU - Balko, J. M. AU - Compton, M. L. AU - Chalkias, S. AU - Gorham, J. AU - Xu, Y. PY - 2016 DA - 2016// TI - Fulminant myocarditis with combination immune checkpoint blockade JO - N Engl J Med VL - 375 UR - https://doi.org/10.1056/NEJMoa1609214 DO - 10.1056/NEJMoa1609214 ID - Johnson2016 ER - TY - JOUR AU - Drobni, Z. D. AU - Alvi, R. M. AU - Taron, J. AU - Zafar, A. AU - Murphy, S. P. AU - Rambarat, P. K. PY - 2020 DA - 2020// TI - Association between immune checkpoint inhibitors with cardiovascular events and atherosclerotic plaque JO - Circulation. VL - 142 UR - https://doi.org/10.1161/CIRCULATIONAHA.120.049981 DO - 10.1161/CIRCULATIONAHA.120.049981 ID - Drobni2020 ER - TY - JOUR AU - Agrawal, N. AU - Khunger, A. AU - Vachhani, P. AU - Colvin, T. A. AU - Hattoum, A. AU - Spangenthal, E. PY - 2019 DA - 2019// TI - Cardiac toxicity associated with immune checkpoint inhibitors: case series and review of the literature JO - Case Rep Oncol VL - 12 UR - https://doi.org/10.1159/000498985 DO - 10.1159/000498985 ID - Agrawal2019 ER - TY - JOUR AU - Larkin, J. AU - Chiarion-Sileni, V. AU - Gonzalez, R. AU - Grob, J. J. AU - Cowey, C. L. AU - Lao, C. D. PY - 2015 DA - 2015// TI - Combined nivolumab and ipilimumab or monotherapy in untreated melanoma JO - N Engl J Med VL - 373 UR - https://doi.org/10.1056/NEJMoa1504030 DO - 10.1056/NEJMoa1504030 ID - Larkin2015 ER - TY - JOUR AU - Postow, M. A. AU - Chesney, J. AU - Pavlick, A. C. AU - Robert, C. AU - Grossmann, K. AU - McDermott, D. PY - 2015 DA - 2015// TI - Nivolumab and ipilimumab versus ipilimumab in untreated melanoma JO - N Engl J Med VL - 372 UR - https://doi.org/10.1056/NEJMoa1414428 DO - 10.1056/NEJMoa1414428 ID - Postow2015 ER - TY - JOUR AU - Yun, S. AU - Vincelette, N. D. AU - Mansour, I. AU - Hariri, D. AU - Motamed, S. PY - 2015 DA - 2015// TI - Late onset ipilimumab-induced pericarditis and pericardial effusion: a rare but life threatening complication JO - Case Rep Oncol Med VL - 2015 ID - Yun2015 ER - TY - JOUR AU - Läubli, H. AU - Balmelli, C. AU - Bossard, M. AU - Pfister, O. AU - Glatz, K. AU - Zippelius, A. PY - 2015 DA - 2015// TI - Acute heart failure due to autoimmune myocarditis under pembrolizumab treatment for metastatic melanoma JO - J Immunother Cancer VL - 3 UR - https://doi.org/10.1186/s40425-015-0057-1 DO - 10.1186/s40425-015-0057-1 ID - Läubli2015 ER - TY - JOUR AU - Escudier, M. AU - Cautela, J. AU - Malissen, N. AU - Ancedy, Y. AU - Orabona, M. AU - Pinto, J. PY - 2017 DA - 2017// TI - Clinical features, management, and outcomes of immune checkpoint inhibitor-related cardiotoxicity JO - Circulation. VL - 136 UR - https://doi.org/10.1161/CIRCULATIONAHA.117.030571 DO - 10.1161/CIRCULATIONAHA.117.030571 ID - Escudier2017 ER - TY - JOUR AU - Amiri-Kordestani, L. AU - Moslehi, J. AU - Cheng, J. AU - Tang, S. AU - Schroeder, R. AU - Sridhara, R. PY - 2018 DA - 2018// TI - Cardiovascular adverse events in immune checkpoint inhibitor clinical trials: A u.S. Food and drug administration pooled analysis JO - J Clin Oncol VL - 36 UR - https://doi.org/10.1200/JCO.2018.36.15_suppl.3009 DO - 10.1200/JCO.2018.36.15_suppl.3009 ID - Amiri-Kordestani2018 ER - TY - JOUR AU - Hu, Y. B. AU - Zhang, Q. AU - Li, H. J. AU - Michot, J. M. AU - Liu, H. B. AU - Zhan, P. PY - 2017 DA - 2017// TI - Evaluation of rare but severe immune related adverse effects in pd-1 and pd-l1 inhibitors in non-small cell lung cancer: a meta-analysis JO - Transl Lung Cancer Res VL - 6 UR - https://doi.org/10.21037/tlcr.2017.12.10 DO - 10.21037/tlcr.2017.12.10 ID - Hu2017 ER - TY - JOUR AU - Gulati, G. AU - Heck, S. L. AU - Ree, A. H. AU - Hoffmann, P. AU - Schulz-Menger, J. AU - Fagerland, M. W. PY - 2016 DA - 2016// TI - Prevention of cardiac dysfunction during adjuvant breast cancer therapy (prada): a 2 × 2 factorial, randomized, placebo-controlled, double-blind clinical trial of candesartan and metoprolol JO - Eur Heart J VL - 37 UR - https://doi.org/10.1093/eurheartj/ehw022 DO - 10.1093/eurheartj/ehw022 ID - Gulati2016 ER - TY - JOUR AU - Avila, M. S. AU - Ayub-Ferreira, S. M. AU - Barros Wanderley, M. R. AU - Dores Cruz, F. AU - Gonçalves Brandão, S. M. AU - Rigaud, V. O. C. PY - 2018 DA - 2018// TI - Carvedilol for prevention of chemotherapy-related cardiotoxicity: The ceccy trial JO - J Am Coll Cardiol VL - 71 UR - https://doi.org/10.1016/j.jacc.2018.02.049 DO - 10.1016/j.jacc.2018.02.049 ID - Avila2018 ER - TY - JOUR AU - Guglin, M. AU - Hartlage, G. AU - Reynolds, C. AU - Chen, R. AU - Patel, V. PY - 2009 DA - 2009// TI - Trastuzumab-induced cardiomyopathy: not as benign as it looks? A retrospective study JO - J Card Fail VL - 15 UR - https://doi.org/10.1016/j.cardfail.2009.04.011 DO - 10.1016/j.cardfail.2009.04.011 ID - Guglin2009 ER - TY - JOUR AU - Zhang, L. AU - Zlotoff, D. A. AU - Awadalla, M. AU - Mahmood, S. S. AU - Nohria, A. AU - Hassan, M. Z. O. PY - 2020 DA - 2020// TI - Major adverse cardiovascular events and the timing and dose of corticosteroids in immune checkpoint inhibitor-associated myocarditis JO - Circulation. VL - 141 UR - https://doi.org/10.1161/CIRCULATIONAHA.119.044703 DO - 10.1161/CIRCULATIONAHA.119.044703 ID - Zhang2020 ER - TY - JOUR AU - Salem, J. E. AU - Allenbach, Y. AU - Vozy, A. AU - Brechot, N. AU - Johnson, D. B. AU - Moslehi, J. J. PY - 2019 DA - 2019// TI - Abatacept for severe immune checkpoint inhibitor-associated myocarditis JO - N Engl J Med VL - 380 UR - https://doi.org/10.1056/NEJMc1901677 DO - 10.1056/NEJMc1901677 ID - Salem2019 ER -